Dámaso Molero
Chief Executive Officer at 3P Biopharmaceuticals SL
Profile
Dámaso Molero is currently the Chief Executive Officer at 3P Biopharmaceuticals SL.
Previously, he held positions as Principal at Shionogi & Co., Ltd., Syntex, Inc., Glaxo, Inc., and Roche & Genentech, Inc. He obtained his undergraduate degree and MBA from the University of Navarra.
Dámaso Molero active positions
| Companies | Position | Start |
|---|---|---|
3P Biopharmaceuticals SL
 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Chief Executive Officer | 01/04/2007 |
Former positions of Dámaso Molero
| Companies | Position | End |
|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
| Syntex, Inc. | Corporate Officer/Principal | - |
| Glaxo, Inc. | Corporate Officer/Principal | - |
Training of Dámaso Molero
| University of Navarra | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SHIONOGI & CO., LTD. | Health Technology |
| Private companies | 3 |
|---|---|
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
| Glaxo, Inc. | |
| Syntex, Inc. | Miscellaneous |
- Stock Market
- Insiders
- Dámaso Molero
